- Report
- November 2024
- 181 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 293 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 178 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 177 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 192 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 297 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 136 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 169 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 285 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 265 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 268 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 373 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 186 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 381 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 169 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 283 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 379 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 269 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 199 Pages
Global
From €5531EUR$5,600USD£4,602GBP
- Report
- November 2024
- 181 Pages
Global
From €5383EUR$5,450USD£4,478GBP
The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more